ResearcherXiamen UniversityActive in the last 2 years
Jianghua Feng
Matched on ORCID iD 0000-0001-8899-2750; OpenAlex author ID A5079769183. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2016: 2 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 10
- Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft models across serial passages. Co-author DOI 10.1186/s12967-025-06787-7↗
- Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction. Co-author DOI 10.1038/s41598-024-56737-4↗
- Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor. Co-author DOI 10.1186/s12885-024-12193-x↗
- Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. Co-author DOI 10.1002/ijc.34208↗
- Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues. Co-author DOI 10.1016/j.jpba.2020.113546↗
- Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study. Co-author DOI 10.21037/gs-20-202↗
- Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. Co-author DOI 10.1186/s12885-017-3703-9↗
- Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. Co-author DOI 10.18632/oncotarget.18057↗
- Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for … Last author DOI 10.1039/c6mb00381h↗
- Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats. Co-author DOI 10.1111/cas.12939↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Heguang Huang · 9 shared papers, 2016–2025 · strength 1.28
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Wen Shi · 7 shared papers, 2016–2025 · strength 0.88
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tis… DOI 10.1016/j.jpba.2020.113546↗
- Pengfei Guo · 5 shared papers, 2020–2025 · strength 0.88
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. DOI 10.1002/ijc.34208↗
- Xianchao Lin · 6 shared papers, 2016–2025 · strength 0.74
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Tianhong Teng · 4 shared papers, 2020–2025 · strength 0.74
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. DOI 10.1002/ijc.34208↗
- Bohan Zhan · 4 shared papers, 2016–2024 · strength 0.44
- Paper Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding prim… DOI 10.1186/s12885-024-12193-x↗
- Paper Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. DOI 10.1186/s12885-017-3703-9↗
- Paper Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. DOI 10.18632/oncotarget.18057↗
- Binbin Wei · 2 shared papers, 2020–2022 · strength 0.28
- Jin Zhang · 1 shared paper, 2024 · strength 0.23
- Yu Pan · 1 shared paper, 2024 · strength 0.22
- Sanxi Wang · 1 shared paper, 2020 · strength 0.13
- Congfei Wang · 1 shared paper, 2020 · strength 0.11
- Heguang Huang · 1 shared paper, 2020 · strength 0.11
- Jieming Xie · 1 shared paper, 2020 · strength 0.11
- Minghuang Chen · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.